Jean‐Pierre Bleuse
Impact in
- Oncology top 10%
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
-
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- William Jacot (7 shared papers)Gilles Romieu (7 shared papers)Simon Thézenas (6 shared papers)Pierre‐Jean Lamy (3 shared papers)Pierre Sénesse (2 shared papers)Marion Carayol (2 shared papers)Grégory Ninot (2 shared papers)H Sancho-Garnier (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (3 papers)BMC Cancer (2 papers)Annals of Oncology (2 papers)Cancer (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Jean‐Pierre Bleuse
21 papers receiving 461 citations
Peers
Comparison fields: 5 of 62
- Oncology 309
- Cancer Research 125
- Pathology and Forensic Medicine 109
- Hepatology 26
- Pediatrics, Perinatology and Child Health 55
Countries citing papers authored by Jean‐Pierre Bleuse
This map shows the geographic impact of Jean‐Pierre Bleuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Bleuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Bleuse more than expected).
Fields of papers citing papers by Jean‐Pierre Bleuse
This network shows the impact of papers produced by Jean‐Pierre Bleuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Bleuse. The network helps show where Jean‐Pierre Bleuse may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean‐Pierre Bleuse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 89 | |
| 2 | 2005 | 84 | |
| 3 | 2015 | 54 | |
| 4 | 2013 | 47 | |
| 5 | 2012 | 40 | |
| 6 | 2018 | 39 | |
| 7 | 2016 | 24 | |
| 8 | 2013 | 18 | |
| 9 | 2004 | 15 | |
| 10 | 2019 | 12 | |
| 11 | 2013 | 12 | |
| 12 | 2010 | 7 | |
| 13 | 2011 | 6 | |
| 14 | [Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord]. | 1998 | 5 |
| 15 | 2004 | 4 | |
| 16 | 2006 | 4 | |
| 17 | 転移性結腸直腸癌(MCRC)患者の第一線治療としてのFOLFIRINOXと併用したセツキシマブを評価する多施設第二相試験の最終結果 | 2009 | 2 |
| 18 | 2017 | 2 | |
| 19 | 2011 | 2 | |
| 20 | 2022 | 1 |
About Jean‐Pierre Bleuse
Jean‐Pierre Bleuse is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 21 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Breast Cancer Treatment Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer-related cognitive impairment studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Vitamin D Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (309 citations), Cancer Research (125 citations), Pathology and Forensic Medicine (109 citations), Hepatology (26 citations) and Pediatrics, Perinatology and Child Health (55 citations). Jean‐Pierre Bleuse has collaborated with scholars based in France and United States. Frequent co-authors include William Jacot, Gilles Romieu, Simon Thézenas, Pierre‐Jean Lamy, Pierre Sénesse, Marion Carayol, Grégory Ninot, H Sancho-Garnier, Sophie Gourgou and Isabelle Romieu. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, BMC Cancer, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.